Practical Pearls for Applying NCCN Guidelines in Advanced Renal Cell Carcinoma

In this segment on advanced renal cell carcinoma, Dr. Geynisman focuses on key principles for applying NCCN guideline recommendations in real-world community practice. Dr. McGregor and Dr. Wulff share practical insights and highlight several “pearls” that can help clinicians navigate an increasingly complex treatment landscape. The discussion emphasizes the importance of individualizing therapy rather than applying guidelines in a rigid manner, taking into account patient-specific factors such as comorbidities, performance status, and prior treatment exposure. The panel also underscores the need to understand the nuances of available regimens, including differences in efficacy, toxicity profiles, and mechanisms of action. In addition, they highlight the value of early planning for sequencing and anticipating future lines of therapy. Overall, the conversation provides actionable guidance for community oncologists, reinforcing that optimal care in advanced renal cell carcinoma requires thoughtful interpretation of guidelines in the context of each patient.